Back to Journals » Research and Reports in Tropical Medicine » Call For Papers

Research and Reports in Tropical Medicine

ISSN: 1179-7282


The following Article Collections/ Thematic Series are currently open for submissions:

Chagas disease: transmission and treatment

Dove Medical Press is pleased to invite you to submit your research to an upcoming Thematic Series on "Chagas disease: transmission and treatment", edited by Editor-in-Chief Dr Mario Rodriguez-Perez in Research and Reports in Tropical Medicine.

Upon submission, please use the promo code NGEUC for 20% off the advertised article processing charge and to indicate that your manuscript will be considered for the Thematic Series of "Chagas disease: transmission and treatment". The deadline for manuscripts is the 31st of May 2024.

For any enquiries, please email Darcy Hodge, Commissioning Editor at [email protected]

About the Thematic Series

Chagas disease is a neglected tropical disease that continues to sweep across endemic areas, typically unnoticed. The asymptomatic nature of the disease can leave diagnosis rates low globally until individuals affected present with symptoms. As a consequence of this there are 6–7 million infections annually, with 10,000 deaths from the disease.

How do we tackle the ongoing Trypanosoma cruzi infections and the subsequent symptoms? As part of this, research must determine the susceptibility to Trypanosoma cruzi amastigotes, including the heterogeneity resistance and receptor antagonists that affect the likelihood of infection.

As researchers convene to develop a vaccine for Chagas disease, we hope to encourage publications that will lessen the "neglected" aspect of this tropical disease. Moreover, improving the understanding of the latent and chronic stages of the infection can pave the way to drug development, including practical molecular and chemotherapy-based techniques. Through this the disease may become treatable and preventable in the regions affected.

The journal is seeking original submissions and review articles on the following topics related to Chagas disease:
• Treatment of the chronic phase
• Efficacy of current drug treatments
• Molecular and chemotherapy-based techniques
• Susceptibility to Trypanosoma cruzi amastigotes
• Metabolic heterogeneity resistance Chagas disease development
• Receptor antagonists for Chagas disease
• Chagas disease vaccine development and potential side effects
• Challenges in understanding immunity correlates
• Transmission rates through intra-domiciliary, active, transplacental and vectorial transmission
• Vector control
• Sentinel animals in the epidemiology of Chagas disease
• Eco-epidemiology of Chagas disease

Submit your manuscript
https://www.dovepress.com/submit_step_1.php

View all papers in this thematic series

Current research and opinion on neglected helminthic infections

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Current research and opinion on neglected helminthic infections" in Research and Reports in Tropical Medicine.

Hundreds of millions of people are infected with helminthic diseases, which occur widely, though not uniformly, throughout the tropical regions of planet Earth. Although simple sanitation and treatment measures have largely eliminated helminthic disease as a serious public health problem in the developed world, helminthic diseases continue to exert a very significant burden in many of the world's most underdeveloped countries and in most of the world's most seriously impoverished regions. Many helminthic diseases are being targeted for control or elimination by national and/or international health organizations; however, most are not treated everywhere they are endemic, and some are not targeted at all. Largely due to historic neglect, research advances in the field of helminthic disease lag behind those of many other infectious diseases and thus there are opportunities to make major and rapid advances in the field helminthic disease research by learning from advances made in more intensively studied areas of infectious disease.

This Collection aims to encourage and support the publication of research reports and comments on issues surrounding not only the helminthic diseases that are targeted for control but also those, like mansonellosis and loiasis, which presently are not.

The Collection welcomes all types of academic articles that are published in the journal, including short and full reports from research studies, reviews and opinion pieces that deal with the diagnostics, surveillance, epidemiology, treatment and control of all helminthic diseases. It also encourages the submission of all types of academic articles on the basic biology and taxonomy of helminthic parasites and vectors and all studies concerning interactions between the causative parasites and their host immune systems. We will also consider articles studies that model and infectious disease dynamics and control strategies and that calculate helminthic disease burdens.

Keywords

  • Neglected Tropical helminthic diseases
  • Filariasis
  • Schistosomiasis
  • Soil transmitted helminths

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code NBOJU to indicate that your submission is for consideration in this Article Collection.

The deadline for submitting manuscripts is 31 October 2024.

Guest Advisors

James Lee Crainey, Oswaldo Cruz Foundation, Brazil

[email protected]

Dr. Crainey has studied filarial parasites and their vectors for more than 20 years. Initially working on the genomics of filarial vectors from Africa and Europe, Dr. Crainey began studying the filarial parasites and vectors of the Amazon after leaving London for Brazil at the end of 2011. Today Dr. Crainey´s research is focused on mansonellosis, the most prevalent filarial disease in the Brazilian Amazon region where he presently lives and works.

Thuy-Huong Ta Tang, Instituto de Salud Carlos III, Spain

[email protected]

Dr. Thuy-Huong Ta Tang is a research scientist based at the Malaria and Neglected Tropical Disease Laboratory of the Instituto de Salud Carlos III, Madrid, Spain. Dr. Tang has worked and published on the subject of filarial disease research and has been involved in studies in both Latin America and Africa. Dr. Tang´s review papers on mansonellosis are among the most cited in the field.

View all papers in this article collection

Strategies against Neglected Tropical Viral Disease

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Strategies against Neglected Tropical Viral Disease" in Research and Reports in Tropical Medicine.

Many tropical diseases have been historically neglected because of lower prevalence, social stigma and lack of profitability. These neglected tropical diseases are endemic to poor developing countries and often promote poverty through long-lasting impacts on quality of life. Dengue and Chikungunya are categorized by the WHO as neglected tropical virus diseases. Like these, other arboviral diseases including ZIKA and Japanese encephalitis also affect developing countries in tropical and sub-tropical regions. The poor are most affected by these arboviral diseases through long-lasting sequelae with huge impact on their socio-economic status. None of these viral diseases have been prioritized in global health programs. Accordingly, adequate effective therapeutic strategies are not available for their management. Thus, despite the debate about classification, all these viral diseases can be considered neglected tropical diseases, in order to attract attention for research and development to devise effective therapeutic strategies.

With increased globalization, climatic change and adaptation of vectors, these arboviral diseases are no longer limited to tropical or sub-tropical countries. They have become global pathogens, and with higher adaptability the disease outbreaks have become more unpredictable. This has attracted wide research attention for development of therapeutic strategies. Efforts to develop new vaccines or specific antivirals have not been very successful. While higher mutability of these viruses has been a challenge for vaccine development, inadequate elucidation of virus-host targets has posed hurdles for effective antiviral development. Nonetheless, concepts of mutable vaccines and success of mRNA vaccines against COVID-19 have fueled hopes for effective vaccine development. Further, greater insights into the virus life-cycle and host response aided by computational techniques have revealed attractive drug targets for antiviral development. Also, there have been efforts to repurpose existing drugs and use herbal drugs/alternative systems for management of these diseases. Considering the fact that virus-induced inflammation is the primary cause of morbidity and mortality, approaches have also been investigated to modulate immune and inflammatory pathways to manage these viral diseases.

Authors are encouraged to submit original research articles and reviews that focus on, but are not limited to, the following areas:

  • Updates in vaccine development against DENV/CHIKV/JEV/ZIKA virus
  • Vaccine design through in silico approach
  • Drug targets for therapeutic intervention against Dengue
  • Updates in drug development strategies against DENV
  • Therapeutic targets for CHIKV infection
  • Drug development strategies against CHIKV
  • Drug development strategies against JEV
  • Drug development strategies against Zika virus
  • Drug repurposing against DENV/CHIKV/JEV /ZIKA virus infection
  • Structure based drug design against DENV/CHIKV/JEV/ZIKA virus
  • Complementary therapy to manage DENV/CHIKV/JEV/ZIKA virus infection
  • Herbal drugs/alternative strategy to manage DENV/CHIKV/JEV/ZIKA virus infection
  • Immune-inflammatory signalling in viral infection
  • Modulation of host factors for management of viral disease


Keywords

  • Tropical virus
  • Antiviral
  • Vaccine development
  • Neglected disease
  • Therapeutic strategy

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code STQQX to indicate that your submission is for consideration in this Article Collection.

The deadline for submitting manuscripts is 30 September 2024.

Guest Advisors

Bharat Bhusan Subudhi, Siksha O Anusandhan Deemed to be University, India

[email protected]

Dr. Bharat Bhusan Subudhi has been working in the field of drug development for last 19 years. He has expertise in drug design, synthesis, drug product development, analysis and toxicological/pharmacological evaluations. Antiviral development is his major research focus.

Soma Chattopadhyay, Institute of Life Sciences, India

[email protected]

Dr. Soma Chattopadhyay has more than 20 years experience in the field of virology/infectious disease biology involving HSV, CHIKV, JEV and SARS-CoV-2. She has expertise in molecular virology, animal models as well as development of viral antibodies. She has worked on drug repurposing and involved in the process for development of strategy for management of CHIKV, HSV, JEV and SARS-CoV-2.

View all papers in this article collection


Call For Papers

Editor-in-Chief: Dr Rodriguez-Perez

To see where Research and Reports in Tropical Medicine is indexed online view the Journal Metrics

What is the advantage to you of publishing in Research and Reports in Tropical Medicine?

  • It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
  • Although Research and Reports in Tropical Medicine receives many papers, unlike most traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
  • The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Research and Reports in Tropical Medicine has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
  • Many authors have found that our peer reviewer’s comments substantially add to their final papers.

To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.

PubMed Central
Research and Reports in Tropical Medicine is indexed on PubMed Central (title abbreviation: Res Rep Trop Med). All published papers in this journal are submitted to PubMed for indexing straight away.

Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so.  Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page.

Yours sincerely
Dr Rodriguez-Perez
Editor-in-Chief
Research and Reports in Tropical Medicine

Email: Editor-in-Chief